Goli Nutrition’s Apple Cider Vinegar Claims Slip On Dosage In Industry Self-Regulation Review
In Appeal, Canadian Firm Argues NAD Review Should Have Stopped Due To Pending Litigation
Executive Summary
Goli Nutrition argues NAD should have declined to review any apple cider vinegar claims because all are challenged in pending litigation. Canadian firm disagrees with NAD findings on Bragg Live challenge and appeals to National Advertising Review Board.
You may also be interested in...
Bragg Live Wants Consumers To Know Efficacy Differs Among Apple Cider Vinegar Formats
Bragg Live says its survey highlights misconceptions consumers have concerning health benefits and efficacy of different delivery formats of apple cider vinegar.
Another Advertising Review For Goli Nutrition: Church & Dwight Challenges Ashwagandha Claims
NAD review of Goli claims, looking at weight loss, physical performance, sexual function and sales claims, recommended it modify advertising to avoid conveying implied product efficacy claims for Ashwagandha Gummies and modify or discontinue qualified physical performance claim about ingredient KSM-66.
Dosing Recommendation In FAQ For Goli Nutrition’s Apple Cider Vinegar Gummy Not A Health Claim
Canadian firm also got agreement from BBB National Program’s appeals panel not to require other changes in ad claims and labeling sought in a challenged by Bragg Live.